Dr. Mirit I. Aladjem is a senior investigator at the National Cancer Institute's developmental therapeutics branch and head of the DNA replication group. She completed her PhD studies at Tel Aviv University.  Dr. Aladjem co-chairs the NIH Cell Cycle Interest Group and the NCI’s Center of Excellence in Chromosome Biology. Her research interests include cellular signaling pathways that modulate chromatin to regulate chromosome duplication and cell cycle progression.